Get the Stockscreener App
2.23
0.00%
0.00
After Hours:
2.24
0.01
+0.45%
Creative Medical Technology Holdings Inc stock is traded at $2.23, with a volume of 93,508.
It is up +0.00% in the last 24 hours and up +4.21% over the past month.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
See More
Previous Close:
$2.23
Open:
$2.2
24h Volume:
93,508
Relative Volume:
2.05
Market Cap:
$8.24M
Revenue:
$6,000
Net Income/Loss:
$-6.00M
P/E Ratio:
-0.9719
EPS:
-2.2945
Net Cash Flow:
$-5.86M
1W Performance:
+0.45%
1M Performance:
+4.21%
6M Performance:
-24.92%
1Y Performance:
+12.63%
1-Day Range:
$2.19
$2.325
1-Week Range:
$2.15
$2.325
52-Week Range:
$1.504
$6.25
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.23 | 8.24M | 6,000 | -6.00M | -5.86M | -2.2945 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
BZLEY Should I Buy - Intellectia AI
Creative Medical (CELZ) Reports Encouraging Pilot Study Results for Ultrasome Therapy - GuruFocus
Creative Medical (CELZ) Reports Promising Osteoarthritis Therapy Results - GuruFocus
BY Technical Analysis & Price Forecast - Intellectia AI
Creative Medical reports positive pilot study results for Ultrasome - Investing.com UK
Creative Medical reports positive pilot study results for Ultrasome By Investing.com - Investing.com Canada
Park Place Technologies Partners with Professional Athlete Genie Bouchard as 'Genie from IT” in New TV Commercial - The Manila Times
Uncertainty Around AI’s Impact on Careers Clouds Students’ College Decisions - The Manila Times
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies - marketscreener.com
Cell-free knee arthritis therapy posts 93% response in pilot study - Stock Titan
JXHLY Forecast — Price Prediction for 2026. Should I Buy JXHLY? - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
NPSKY Technical Analysis & Stock Price Forecast - Intellectia AI
BHPCD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Iran Hormuz Strait Crisis: Oil Market Impact & Energy Investment Strategy 2026 - Intellectia AI
NAII Technical Analysis & Price Forecast - Intellectia AI
MITT Technical Analysis & Price Forecast - Intellectia AI
RWAY Technical Analysis & Price Forecast - Intellectia AI
Creative Medical Technology Holdings, Inc. 2025 Annual Report: Executive Summary, Compensation, and Compliance Disclosures - Minichart
IBEX Technical Analysis & Price Forecast - Intellectia AI
TOVXPrice, Charts & Blockchain Insights - Intellectia AI
Creative Medical (NASDAQ: CELZ) details 2025 pay, ownership and deals - Stock Titan
VMC Technical Analysis & Price Forecast - Intellectia AI
GE Vernova Stock Analysis 2026: Q1 Earnings Beat Signals Powerhouse Momentum - Intellectia AI
HDSN Technical Analysis & Price Forecast - Intellectia AI
CreativeMed (CELZ) Volatility Analysis | Q3 2025: Profit SurprisesBest Pick - Cổng thông tin điện tử tỉnh Lào Cai
PVH Technical Analysis & Price Forecast - Intellectia AI
VIVK Technical Analysis & Price Forecast - Intellectia AI
Form 10-KAnnual report [Section 13 and 15(d), not S-K Item 405] - ADVFN
CreativeMed (CELZ) Stock Moving VWAP (Advances) 2026-04-18Open Stock Signal Network - Newser
$ADA PE Ratio & Valuation, Is $ADA Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Breakout Zone: Can Creative Medical Technology Holdings Inc continue delivering strong returns2026 Sentiment & Capital Efficient Trading Techniques - baoquankhu1.vn
Growth Review: What is the earnings history of Creative Medical Technology Holdings IncQuarterly Trade Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Street Watch: Does AVPTW have a sustainable dividendPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug Opening: Is Sky Harbour Group Corporation being accumulated by smart money2026 Earnings Impact & Stepwise Trade Signal Guides - baoquankhu1.vn
CREATIVE MEDICAL TECHNOLOGY HOLDINGS Operating Margin %: -64 - GuruFocus
Income Plays: Is Creative Medical Technology Holdings Inc forming bullish engulfing patternsIndex Update & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Aug Weekly: Is Starwood Property Trust Inc a top pick in the sectorLayoff News & Stepwise Trade Execution Plans - baoquankhu1.vn
New Highs: What is ACCOs market positionPortfolio Update Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long - Yahoo Finance
Leading Companies Enhancing Their Presence in the Cancer Anorexia-Cachexia Syndrome (CACS) Market - openPR.com
TKWY-NL PE Ratio & Valuation, Is TKWY-NL Overvalued - Intellectia AI
What are analysts price targets for Royal Caribbean Cruises LtdEntry Point & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Alphabet, Inc. | History, Products, & Business Segments - Britannica
KPET Ultra Paceline Corp 2026 Audited Balance Sheet and Financial Statement Highlights - Minichart
NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI
NXL PE Ratio & Valuation, Is NXL Overvalued - Intellectia AI
CELZ (Creative Medical Technology Holdings) Policyholder Fu - GuruFocus
When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Sahm
Clean Energy Technologies, Inc. (CETY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):